Vector-derived factor IX coagulant activity was sustained in all the participants, with a mean (±SD) steady-state factor IX coagulant activity of 33.7±18.5% (range, 14 to 81).

New Zealand-based energy infrastructure company Vector Ltd. (VCT.NZ) said it expected a year of steady earnings, but moved to damp expectations that Auckland's booming population will be a growth ...